2011
DOI: 10.33549/physiolres.932201
|View full text |Cite
|
Sign up to set email alerts
|

The Effect of Indapamide on Development of Myocardial Hypertrophy and Fibrosis in L-NAME-Induced Hypertension in Rat

Abstract: The aim of this study was to analyze the effect of indapamide and its combination with ACE inhibitor (captopril) and antioxidant (ProvinolsTM) on both myocardial hypertrophy and fibrosis. Wistar rats were treated with L-NAME (40 mg/kg/day, L); L-NAME plus indapamide (1 mg/kg/day), or captopril (10 mg/kg/day), or ProvinolsTM (40 mg/kg/day), or combination of indapamide with captopril, and indapamide with ProvinolsTM for 7 weeks. Blood pressure (BP), LV hypertrophy and fibrosis were determined. The content of co… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
6
0

Year Published

2012
2012
2020
2020

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 8 publications
(6 citation statements)
references
References 39 publications
(23 reference statements)
0
6
0
Order By: Relevance
“…By contrast, collagen type III mainly forms a slender fiber, and its stretch and rebound resilience are strong [ 19 ]. Increased levels of collagen type I can increase myocardial stiffness, while increased levels of collagen type III can increase ventricular compliance; therefore, the collagen type I/III ratio can be a good reflection of the degree of myocardial fibrosis [ 20 ]. In addition, a variety of myocardial collagen metabolism products, including PICP, PIIINP, and CTX-I, are involved in the process of myocardial fibrosis [ 21 ].…”
Section: Discussionmentioning
confidence: 99%
“…By contrast, collagen type III mainly forms a slender fiber, and its stretch and rebound resilience are strong [ 19 ]. Increased levels of collagen type I can increase myocardial stiffness, while increased levels of collagen type III can increase ventricular compliance; therefore, the collagen type I/III ratio can be a good reflection of the degree of myocardial fibrosis [ 20 ]. In addition, a variety of myocardial collagen metabolism products, including PICP, PIIINP, and CTX-I, are involved in the process of myocardial fibrosis [ 21 ].…”
Section: Discussionmentioning
confidence: 99%
“…L-NAME administration includes via drinking water, gavage and subcutaneous injection. Although most of the works induce hypertension through drinking water, 38,6,[9][10][11][12]8,15 Ribeiro et al 8 observed that average dairy water intake per box was 26% lower in L-NAME-treated rats than in controls. This way, we chose gavage administration to be sure on the dose ingested by rats and to be sure all rats were receiving the same dose.…”
Section: Experimental Protocolmentioning
confidence: 99%
“…[6][7][8] Several studies have administered in vivo an inhibitor of NO biosynthesis, the No-nitro-L-arginine methyl ester hydrochloride (L-NAME), an L-arginine analogue, to induce hypertension in rats. [9][10][11][12][13][14][15] In hypertension, the production of reactive oxygen species (ROS) is increased by various means and it can also cause other vascular diseases and disorders. 16 However, it still remains unclear whether increased ROS levels are a cause or a consequence of high BP.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…Increases in collagen content may cause myocardial dysfunction due to impairment of the ventricular compliance, as well as changes in cardiac geometry. The literature suggests that decreased NO synthesis promotes the activation of neurohormonal systems and growthpromoting factors that could induce myocardial fibrosis (38). Cardiac hypertrophy refers to the process of cardiac thickening and remodeling, and may be due to cardiac pathology or long-term exercise training.…”
Section: Discussionmentioning
confidence: 99%